| abstract |
The invention relates to a pharmaceutical preparation containing at least one pyrazolo(4, 3-d)pyrimidine or thienopyrimidine phosphodiesterase V inhibitor and at least one nitrate for producing a pharmaceutical for the treatment of angina, hypertension, pulmonary hypertension, congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), pulmonary heart disease, right ventricular failure, arteriosclerosis, conditions of reduced patency of the heart vessels, peripheral vascular diseases, apoplexy, bronchitis, allergic asthma, chronic asthma, allergic rhinitis, glaucoma, irritable bowel syndrome, tumours, kidney failure and cirrhosis of the liver. |